期刊文献+

软肝煎对非酒精性脂肪肝大鼠肝纤维化的预防作用 被引量:3

The study on the prevention of nonalcoholic steatohepatitis with fibrosis by Ruangan compound
下载PDF
导出
摘要 目的:观察软肝煎对非酒精性脂肪肝大鼠肝纤维化的预防作用,并探讨其作用机制。方法:将38只SD大鼠随机分为4组,除正常组(N)外,其余3组即模型组(M)、软肝煎低剂量组(L)、软肝煎高剂量组(H)大鼠用高脂饲料喂养共16周,制备大鼠非酒精性脂肪肝模型。L组、H组大鼠以软肝煎低、高剂量灌胃,1次/d,共12周;N、M组大鼠以等量生理盐水灌胃。观察各组大鼠肝组织病理变化及TGF-β1阳性表达情况,检测血清PCⅢ、CⅣ、HA、LN水平,并进行比较。结果:M组大鼠肝组织呈脂肪变、炎性细胞浸润、肝细胞坏死、纤维组织明显增生,L、H组大鼠肝组织病理表现较M组明显减轻;M组大鼠TGF-β1阳性表达较N组增高(P<0·05),而H组较M组则降低(P<0·05);M组大鼠各项血清学指标较N组明显升高(P<0·05),而L、H组较M则明显降低(均P<0·05),且此4项指标与肝纤维化存在正相关。结论:软肝煎不仅可以治疗脂肪肝、高脂血症,而且还具有确切地预防非酒精性脂肪肝纤维化作用。 Objective: To study the preventive effect of Ruangan compound in nonalcoholic steatohepatitis with fibrosis. Methods: Thirty-eight SD rats were divided randomly into four groups: control group was fed with normal diet; model group, low dose group and high dose group were fed with a fat-rich diet. After 16 weeks, low dose group and high dose group were perfused with Chinese herbs for 12 weeks. The serum levels of HA, LN, PCⅢ and CⅣ were measured. Liver pathology and positive express degree of cytokine TGF-β1 were observed. Results: Pathology: All rats of model group developed steatosis mixed with inflammatory cell infiltration and necrosis. Central veins peripheral fibrosis and perisinosodial fibrosis also could be observed in model group. Low dose group and high dose group were better than model group. Serum levels: Model group was significantly higher than control group ( P 〈 0. 05 ) . Compared with model group, low dose group and high dose group had significantly lower levels (P 〈 0. 05 ) . Cytokine TGF-β1 : Compared with control group, model group had significantly higher levels (P 〈 0. 05 ) . High dose group was significantly lower than model group ( P 〈 0. 05 ) . Conclusion: Ruangan Compound not only can therapy nonalcoholic adiposis hepatica, hyperlipoidemia and protect hepatocyts from injury, but also can prevent the emergence of nonalcoholic steatohepatitis with fibrosis.
出处 《中西医结合肝病杂志》 CAS 2008年第3期164-166,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词 非酒精性脂肪性肝病 软肝煎 中药 肝纤维化 转化生长因子-Β1 大鼠 nonalcoholic fatty liver disease Ruangan compound, traditional Chinese mdeicine hepatic fibrosis TGF- β1 rats
  • 相关文献

参考文献6

  • 1栗凤霞,吕宗舜,王绪林.复方中药治疗非酒精性脂肪性肝病的实验研究[J].中国药物与临床,2005,5(2):108-111. 被引量:19
  • 2中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5):327-328. 被引量:611
  • 3Day CP, James OFW. Steatohepatitis: a tale of two hits? Gastroenterology, 1998, 114:842-845
  • 4Farrel GC. Nonalcoholic steatohepatitis: what is it and why is it important in the Asia-Pacific region. J Gastroenterol Hepatol, 2003, 18: 124-138
  • 5Bergamini CM, Gambetti S, Dondi A, et al. Oxygen, reactive oxygen species and tissue damage. Curr Pharm, 2004, 10:1611-1626
  • 6Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol, 2004, Dec 1 (2) : 98-105

二级参考文献9

  • 1Liangpunsakul S,Chalasani N. Treatment of nonalcoholic fatty liver disease. Curr Treat Option Gastroenterol, 2003,6(6):455-463.
  • 2Younossi ZM.Nonalcoholic fatty liver diseases.Curr Gastroenterol Rep,1999,1(1):57-62.
  • 3Scheen AJ,Luyckx FH. Nonalcoholic steatohepatitis and insulin resistance:interface between gastroenterologists and endocrinologists. Acta Clin Belg,2003,58(2):81-91.
  • 4Day CP,James OFW. Steatohepatitis: a tale of two hits? Gastroenterology, 1998,114: 842-845.
  • 5(6):363-365.8.Rao MS,Papreddy K,Musunuri S,et al. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferatoractivated receptor: a ligand in rats. In Vivo,2002,16(2):145-152.
  • 6Hashimoto T, Fujita T, Usada N, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferators-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. J Biol Chem,1999,274 (27):19228-19235.
  • 7徐正婕,范建高,王国良,丁晓东,田丽艳,郑晓英.乳果糖对大鼠非酒精性脂肪性肝炎模型形成的影响[J].中华消化杂志,2003,23(2):97-100. 被引量:21
  • 8曾民德.重视非酒精性脂肪性肝病的研究[J].中华肝脏病杂志,2003,11(2):69-70. 被引量:71
  • 9范建高.非酒精性脂肪肝的病因和发病机制[J].胃肠病学,2003,8(6):363-365. 被引量:34

共引文献628

同被引文献73

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部